e-learning
resources
Stockholm 2002
Monday 16.09.2002
New anti-inflammatory agents for asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Oral theophylline benefits stable 'irreversible' chronic obstructive pulmonary disease: a systematic review and meta-analysis
F. S. F. Ram, S. Cendon (London, United Kingdom; Sau Paulo, Brazil)
Source:
Annual Congress 2002 - New anti-inflammatory agents for asthma and COPD
Session:
New anti-inflammatory agents for asthma and COPD
Session type:
Oral Presentation
Number:
2329
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. S. F. Ram, S. Cendon (London, United Kingdom; Sau Paulo, Brazil). Oral theophylline benefits stable 'irreversible' chronic obstructive pulmonary disease: a systematic review and meta-analysis. Eur Respir J 2002; 20: Suppl. 38, 2329
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Safety and benefits of beta-blockers in chronic obstructive pulmonary disease: a review of current evidence and meta-analysis
Source: International Congress 2018 – Cardiovascular morbidities in COPD
Year: 2018
Tiotropium for the treatment of stable chronic obstructive pulmonary disease: A meta-analysis of clinically relevant outcomes
Source: Annual Congress 2010 - COPD: management
Year: 2010
Acute exacerbations of chronic obstructive pulmonary disease: current recommendations review and quality of evidence analysis.
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020
Early supported discharge/hospital at home for exacerbation of chronic obstructive pulmonary disease, A review and meta-analysis
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
The effect of methlyxanthines as adjunct to corticosteroids among chronic obstructuve pulmonary disease patients in acute exacerbation: a systematic review and meta-analysis
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
Arm training in patients with chronic obstructive pulmonary disease: a systematic review
Source: Annual Congress 2009 - Improving outcome through exercise training or physiotherapy interventions
Year: 2009
A preliminary meta-analysis of long-term inhaled steroids for stable chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 486s
Year: 2001
Mild cognitive impairment in chronic obstructive pulmonary disease and chronic heart failure: A systematic review and meta-analysis
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016
Long-term use of inhaled glucocorticoids in stable chronic obstructive pulmonary disease patients and risk of diabetes mellitus: systematic review of the literature
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018
Global burden of COPD: systematic review and meta-analysis
Source: Eur Respir J 2006; 28: 523-532
Year: 2006
Misdiagnosed COPD: systematic review and meta-analysis
Source: Annual Congress 2007 - Delivering respiratory care: the challenges for primary care
Year: 2007
Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease: A systematic review and meta-analysis
Source: International Congress 2015 – COPD: notable points
Year: 2015
²Hospital at home² versus inpatient care for patients with acute exacerbations of chronic obstructive pulmonary disease: cochrane systematic review and meta-analysis
Source: Eur Respir J 2003; 22: Suppl. 45, 445s
Year: 2003
Anti-interleukin 5 treatment in moderate to severe eosinophilic chronic obstructive pulmonary disease: a systematic review and meta-analysis
Source: International Congress 2019 – Advances in COPD pharmacology
Year: 2019
Prevalence of metabolic syndrome among patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015
Can roflumilast improve clinical outcomes in moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016
Hypertension in chronic obstructive pulmonary disease (COPD): A review of current practice
Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Year: 2020
Optimizing chronic obstructive pulmonary disease (COPD) diagnosis and management to reduce healthcare costs: Systematic review and modeling
Source: Annual Congress 2013 –Health economics of airway diseases
Year: 2013
Epidemiology of chronic obstructive pulmonary disease in Brazil: a systematic review and meta-analysis
Source: International Congress 2019 – COPD: epidemiology and spirometry
Year: 2019
The report of nationwide quality assessment in chronic obstructive pulmonary disease
Source: International Congress 2019 – Epidemiology of airway diseases in primary care
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept